Previous Close | 140.03 |
Open | 138.00 |
Bid | 137.74 x 200 |
Ask | 137.88 x 100 |
Day's Range | 135.27 - 139.92 |
52 Week Range | 62.55 - 170.47 |
Volume | |
Avg. Volume | 3,864,580 |
Market Cap | 52.849B |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -15.60 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 134.65 |
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...